The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) unveiled a new white paper, Harm Reduction Denied in Asia Pacific, during the “Asia Day” event at Good Cop 2.0 in Geneva, coinciding with FCTC COP11. The paper examines inconsistencies in WHO’s tobacco control approach across the SEARO and WPRO regions, drawing on official WHO data such as the Global Report on Trends in Tobacco Use 2000–2030 and the Global Health Observatory. It calls for reform in the application of harm reduction under the FCTC, proposing evidence-based policy solutions that align with public health objectives while respecting human rights principles. Among its recommendations are regulation rather than prohibition of safer nicotine products, inclusion of consumers and independent scientists in policymaking, and greater transparency and accountability in FCTC processes.
CAPHRA emphasizes that denying harm reduction perpetuates preventable disease, encourages illicit trade, and undermines trust in public health systems. The white paper urges WHO member states at COP11 to reaffirm Article 1(d) of the FCTC by recognizing harm reduction as a key pillar of tobacco control and to adopt pragmatic, science-driven policies that protect lives. The full report is available here.




